Top Markets
#1 0G 0G +42.31%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.68%
#3 Useless Coin Useless Coin +35.33%
#4 SAFEcoin SAFEcoin +30.67%
#5 StonkBroker StonkBroker +27.91%
#6 Arbitrum Arbitrum +26.80%
#7 Notcoin Notcoin +19.19%
#8 Full Moon Full Moon +18.20%
#9 Zora Zora +16.97%
#10 Curve DAO Curve DAO +16.15%
Coin of the day
0G 0G
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Pozycja w akcjach #13821
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Cena akcji
$12.63
Kapitalizacja rynkowa
$458.19M
Zmiana (1 dzień)
-3.26%
Zmiana (1 rok)
-
Kraj
US
Handel Evommune, Inc. (EVMN)

Kategoria

Healthcare
Historia ceny akcji dla Evommune, Inc. (EVMN)
Najwyższa cena zamknięcia: $13.94 dnia 2026-08-01

Najniższa cena zamknięcia: $19.25 dnia 2025-11-01
Historia cen akcji firmy Evommune, Inc. od 2025 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 9.44%
2025 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH